Arrivent Biopharma Inc (AVBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Operating Expenses | 46,111 | 38,823 | 38,316 | 33,623 | 66,772 |
| Operating Income | -46,111 | -38,823 | -38,316 | -33,623 | -66,772 |
| Other Income | 2,791 | 3,279 | 3,338 | 2,224 | 2,385 |
| Pre-tax Income | -43,320 | -35,544 | -34,978 | -31,399 | -64,387 |
| Net Income Continuous | -43,320 | -35,544 | -34,978 | -31,399 | -64,387 |
| Net Income | $-43,320 | $-35,544 | $-34,978 | $-31,399 | $-64,387 |
| EPS Basic Total Ops | -0.96 | -0.69 | -0.83 | -0.90 | -1.90 |
| EPS Basic Continuous Ops | -0.96 | -0.69 | -0.83 | -0.90 | -1.90 |
| EPS Diluted Total Ops | -0.96 | -0.69 | -0.83 | -0.90 | -1.90 |
| EPS Diluted Continuous Ops | -0.96 | -0.69 | -0.83 | -0.90 | -1.90 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.78 | -0.83 | -0.90 | -1.90 |
| EBITDA(a) | $-46,670 | $-38,823 | $-38,316 | $-33,623 | $-66,772 |